日本 横須賀 の 中学 生 の ヘリコバクター 型 菌 の 検診 と 根絶: 流行 率,根絶 率 と 課題
Yoshika Saito1, Hiroaki Saito1,2,3, Tomoki Matsuda1
1Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
Journal of gastroenterology and hepatology
|September 4, 2025
まとめ
日本における学校でのヘリコバクター・パイロリ (H. pylori) 検診は低感染率を示しているが,参加と治療の成功における課題を強調している. 子供を中心とした有効な H. pylori 根絶プログラムには 関与の改善が不可欠です
科学分野:
- 公衆衛生
- 感染症 疫学
- 小児の健康
背景:
- ヘリコバクター・パイロリ (H. pylori) 感染は胃がんの重要な危険因子です.
- H. pyloriを早期に根絶することは,癌のリスクを軽減するために極めて重要です.
- 日本では,学校での H. pylori のスクリーニングプログラムがますます採用されています.
研究 の 目的:
- 高校生における H. pylori 検診のための行政イニシアチブを評価する.
- 子供を中心とした H. pylori のスクリーニングと根絶の取り組みにおける課題を特定する.
- 参加率,治療効果,家族伝染パターンの分析.
主な方法:
- 日本の横須賀市で実施された2019~2021年の人口ベースのスクリーニングプログラム.
- 高校2年生を対象とした2段階の検査方法 (尿抗体,尿素呼吸検査)
- 根絶治療の結果,副作用,および家族感染状況のモニタリング
主要な成果:
- 6270人のスクリーニングを受けた学生のうち,H. pylori感染率は1. 2%と確認された.
- 第一線治療の成功率は52. 9%で,第二線治療の成功率は94. 7%に達した.
- 感染した学生の48.5%はH. pylori陽性である親戚であり,家族からの感染を示唆している.
結論:
- H. pyloriの流行は都市部の日本の初中生では低く,根絶の成功は適度である.
- 低参加率と中退率は 強化された関与戦略を必要とします
- 総合的なH.ピロリ検診と治療プログラムには 関与の改善が不可欠です
さらに関連する動画
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
219
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
492
関連する概念動画
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
01:26Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145
01:30Peptic Ulcer Disease I: Introduction
285
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
285
01:23Gastritis III: Clinical Manifestations and Management
466
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
466
01:28Peptic Ulcer Disease II: Pathophysiology
827
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
827